Liposomal Quercetin‐Loaded Biomimetic Scaffolds Manage Mechanical Overload in Maxillofacial Regeneration by Stabilizing the β‐Actin/YAP Mechanosensing Axis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Rui Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Quercetin, Bone Regeneration, Actins, Liposomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Research Project of Tianjin Municipal Education Commission, Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Critical‐sized maxillofacial bone defects are frequently exposed to pathological mechanical overload (MO), which disrupts cellular mechanosensing and compromises bone regeneration. However, strategies that protect osteogenic cells from overload‐induced mechanobiological dysfunction remain limited. Here, we develop a biomimetic scaffold incorporating liposomal quercetin (LQ) into a collagen/silk fibroin/nano‐hydroxyapatite matrix (LQ‐CSH) to restore osteoblast function under pathological loading conditions. MO induces cytoskeletal disorganization and oxidative stress, leading to inactivation of the mechanotransducer Yes‐associated protein (YAP). LQ treatment markedly reduces intracellular oxidative stress, preserves β‐actin cytoskeletal integrity, and restores YAP nuclear localization, thereby rescuing osteoblast proliferation and osteogenic differentiation. Pharmacological inhibition of β‐actin polymerization or YAP signaling abolishes these protective effects, confirming the critical role of the β‐actin/YAP mechanosensing axis. In a rabbit mandibular critical‐sized defect model with simulated occlusal overload, LQ‐CSH scaffolds significantly enhance bone regeneration, improving bone volume fraction, mineral density, and trabecular architecture compared with control scaffolds. These findings highlight a mechanochemical strategy that protects osteogenic cells from overload‐induced dysfunction and provide a promising therapeutic approach for bone regeneration in mechanically hostile environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
- Tianjin Key Laboratory of Oral and Maxillofacial Function Reconstruction, Tianjin, China.
- Tianjin's Clinical Research Center for Cancer, Tianjin, China.
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
- Tianjin Medical University, Tianjin, China.
- Department of Endodontics, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Förderung
- Research Project of Tianjin Municipal Education Commission
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Luo, R., Wang, T., Zhang, T., Wang, Y., Sun, M., Liu, Y., Shen, J., & Li, R. (2026). Liposomal Quercetin‐Loaded Biomimetic Scaffolds Manage Mechanical Overload in Maxillofacial Regeneration by Stabilizing the β‐Actin/YAP Mechanosensing Axis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505818
Vancouver
Luo R, Wang T, Zhang T, Wang Y, Sun M, Liu Y, et al. Liposomal Quercetin‐Loaded Biomimetic Scaffolds Manage Mechanical Overload in Maxillofacial Regeneration by Stabilizing the β‐Actin/YAP Mechanosensing Axis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505818
BibTeX
@article{Luo2026,
author = {Luo, Rui and Wang, Tian and Zhang, Tongmei and Wang, Yanan and Sun, Mingzhu and Liu, Yaowei and Shen, Jun and Li, Ruixin},
title = {Liposomal Quercetin‐Loaded Biomimetic Scaffolds Manage Mechanical Overload in Maxillofacial Regeneration by Stabilizing the β‐Actin/YAP Mechanosensing Axis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505818}
}
EUVIMED